, Tracking Stock Market Picks
Enter Symbol:
China Jo Jo Drugstores Inc (CJJD) [hlAlert]

Mkt Outperform
down 66.49 %

China Jo Jo Drugstores Inc: OTC:CJJD quotes & news (CJJD) rated Mkt Outperform with price target $7 by Rodman & Renshaw

Posted on: Friday,  Nov 26, 2010  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform China Jo Jo Drugstores Inc (NASDAQ: CJJD) on 11/26/2010. Previously Rodman & Renshaw rated Mkt Outperform China Jo Jo Drugstores
Inc (NASDAQ: CJJD) on 08/09/2010., when the stock price was $5.70. Since then, China Jo Jo Drugstores Inc has lost 66.49% as of 08/28/2015's recent price of $1.91.
If you would have followed the previous Rodman & Renshaw's recommendation on CJJD, you would have lost 66.49% of your investment in 1845 days.

China Jo-Jo Drugstores, Inc, formerly Kerrisdale Mining Corporation, is an exploration-stage company. The Company does not own an interest in any property, but has the right to conduct exploration activities on one property referred to herein as the Kerrisdale Property. The Kerrisdale Property is a mineral claim consisting of approximately 369.5 hectares (approximately 910 acres) located in the south-center region of British Columbia, Canada. The Company plans to engage in the exploration of mineral properties and to exploit mineral reserves it discovers that demonstrate economic feasibility, if any. The Company has no plans to merge with or acquire another business entity.On September 17, 2009, the Company completed a reverse merger transaction with Renovation Investment (Hong Kong) Co., Ltd. (Renovation), through which the Company acquired Renovation's retail pharmacy chain business in the People's Republic of China.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2010 8:25 AM Buy
4.84 7.00
as of 12/31/2010
1 Week up  10.76 %
1 Month up  2.88 %
3 Months down  -10.09 %
1 YTD up  10.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/9/2010 10:25 AM Buy
5.70 8.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy